Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 22, 2022

SELL
$0.63 - $1.59 $50,022 - $126,246
-79,400 Closed
0 $0
Q4 2021

Jan 14, 2022

BUY
$1.27 - $2.42 $381 - $726
300 Added 0.38%
79,400 $101,000
Q3 2021

Oct 12, 2021

BUY
$2.15 - $3.82 $13,545 - $24,066
6,300 Added 8.65%
79,100 $172,000
Q2 2021

Jul 16, 2021

BUY
$2.89 - $4.45 $18,785 - $28,925
6,500 Added 9.8%
72,800 $273,000
Q1 2021

Apr 14, 2021

SELL
$2.9 - $4.09 $2,610 - $3,681
-900 Reduced 1.34%
66,300 $216,000
Q4 2020

Jan 11, 2021

SELL
$3.38 - $5.14 $1,014 - $1,542
-300 Reduced 0.44%
67,200 $229,000
Q3 2020

Oct 19, 2020

BUY
$2.99 - $4.9 $108,596 - $177,968
36,320 Added 116.48%
67,500 $275,000
Q1 2020

Apr 13, 2020

SELL
$1.83 - $3.45 $13,706 - $25,840
-7,490 Reduced 19.37%
31,180 $73,000
Q4 2019

Jan 17, 2020

SELL
$3.5 - $10.35 $10,605 - $31,360
-3,030 Reduced 7.27%
38,670 $141,000
Q3 2019

Oct 24, 2019

BUY
$7.03 - $9.7 $14,763 - $20,370
2,100 Added 5.3%
41,700 $346,000
Q2 2019

Jul 15, 2019

BUY
$7.36 - $11.26 $1,472 - $2,252
200 Added 0.51%
39,600 $320,000
Q1 2019

Apr 15, 2019

BUY
$9.08 - $11.84 $11,268 - $14,693
1,241 Added 3.25%
39,400 $421,000
Q4 2018

Jan 14, 2019

SELL
$6.39 - $16.99 $34,767 - $92,442
-5,441 Reduced 12.48%
38,159 $334,000
Q3 2018

Oct 16, 2018

BUY
$16.52 - $24.82 $28,084 - $42,194
1,700 Added 4.06%
43,600 $732,000
Q2 2018

Jul 18, 2018

BUY
$14.31 - $21.75 $24,327 - $36,975
1,700 Added 4.23%
41,900 $878,000
Q1 2018

Apr 18, 2018

BUY
$16.09 - $23.07 $19,308 - $27,684
1,200 Added 3.08%
40,200 $647,000
Q4 2017

Jan 16, 2018

BUY
$13.36 - $20.73 $109,552 - $169,986
8,200 Added 26.62%
39,000 $739,000
Q3 2017

Oct 16, 2017

BUY
$8.75 - $14.07 $269,500 - $433,356
30,800
30,800 $433,000

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0

About SPECTRUM PHARMACEUTICALS INC


  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Louisiana State Employees Retirement System Portfolio

Follow Louisiana State Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.